Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low–Expressing Advanced Breast Cancer: Results From a Phase Ib Study

JOURNAL ARTICLE published 10 June 2020 in Journal of Clinical Oncology

Authors: Shanu Modi | Haeseong Park | Rashmi K. Murthy | Hiroji Iwata | Kenji Tamura | Junji Tsurutani | Alvaro Moreno-Aspitia | Toshihiko Doi | Yasuaki Sagara | Charles Redfern | Ian E. Krop | Caleb Lee | Yoshihiko Fujisaki | Masahiro Sugihara | Lin Zhang | Javad Shahidi | Shunji Takahashi